Katharina Tabea Jungo, PhD
Katharina Tabea Jungo, PhD
Other namesKatharina Jungo
Brigham and Women's Hospital and Harvard Medical School
Verified email at - Homepage
Cited by
Cited by
Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial
MR Blum, BTGM Sallevelt, A Spinewine, D O’Mahony, E Moutzouri, ...
BMJ 374, 2021
Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial
L Adam, E Moutzouri, C Baumgartner, AL Loewe, M Feller, ...
BMJ open 9 (6), e026769, 2019
What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study-a primary care-based survey
Z Rozsnyai, KT Jungo, E Reeve, RKE Poortvliet, N Rodondi, J Gussekloo, ...
BMC Geriatrics 20 (1), 1-11, 2020
Sponsorship of national and regional professional paediatrics associations by companies that make breast-milk substitutes: evidence from a review of official websites
LM Grummer-Strawn, F Holliday, KT Jungo, N Rollins
BMJ open 9 (8), e029035, 2019
Potentially inappropriate medication and attitudes of older adults towards deprescribing
A Achterhof, Z Rozsnyai, E Reeve, KT Jungo, C Floriani, R Poortvliet, ...
PLoS ONE 15 (10), 2020
How general practitioners would deprescribe in frail oldest-old with polypharmacy—the LESS study
S Mantelli, KT Jungo, Z Rozsnyai, E Reeve, CH Luymes, RKE Poortvliet, ...
BMC family practice 19 (1), 169, 2018
Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy
A Bhadhuri, P Kind, P Salari, KT Jungo, B Boland, S Byrne, S Hossmann, ...
Health and Quality of Life Outcomes 18 (317), 2020
Astana Declaration: A New Pathway for Primary Health Care
KT Jungo, D Anker, L Wildisen
International Journal of Public Health 65 (5), 511-512, 2020
General practitioners' deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries
KT Jungo, S Mantelli, Z Rozsnyai, A Missiou, B Gerasimovska Kitanovska, ...
BMC Geriatrics 21 (19), 2021
Utilization and Spending on Potentially Inappropriate Medications by US Older Adults with Multiple Chronic Conditions using Multiple Medications
KT Jungo, S Streit, JC Lauffenburger
Archives of Gerontology and Geriatrics 93, 2021
Impact of the COVID-19 Pandemic on the Intensity of Health Services Use in General Practice: A Retrospective Cohort Study
Y Rachamin, O Senn, S Streit, J Dubois, MJ Deml, KT Jungo
International Journal of Public Health, 2021
The impact of the COVID-19 pandemic on the continuity of care for at-risk patients in Swiss primary care settings: A mixed-methods study
MJ Deml, J Minnema, J Dubois, O Senn, S Streit, Y Rachamin, K Jungo
Social Science & Medicine, 2022
‘Optimising PharmacoTherapy In the multimorbid elderly in primary CAre’(OPTICA) to improve medication appropriateness: study protocol of a cluster randomised controlled trial
KT Jungo, Z Rozsnyai, S Mantelli, C Floriani, AL Lwe, F Lindemann, ...
BMJ open 9 (9), e031080, 2019
Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity
BTGM Sallevelt, CJA Huibers, JMJ Op Heij, ...
Drugs & Aging, 2021
Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trial
KT Jungo, R Meier, F Valeri, N Schwab, C Schneider, E Reeve, M Spruit, ...
BMC Family Practice 22 (1), 1-14, 2021
Patient factors associated with new prescribing of potentially inappropriate medications in multimorbid US older adults using multiple medications
KT Jungo, S Streit, JC Lauffenburger
BMC Geriatrics 21 (1), 1-12, 2021
Megatrends in Healthcare: Review for the Swiss National Science Foundation’s National Research Programme 74 (NRP74) “Smarter Health Care”
M Deml, KT Jungo, M Maessen, A Martani, A Ulyte
Public Health Rev, 2022
Optimising prescribing in older adults with multimorbidity and polypharmacy in primary care (OPTICA): cluster randomised clinical trial
KT Jungo, AK Ansorg, C Floriani, Z Rozsnyai, N Schwab, O Stalder, ...
BMJ 381 (e074054), 2023
Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study
P Salari, C O’Mahony, S Henrard, P Welsing, A Bhadhuri, N Schur, ...
PloS one 17 (4), e0265507, 2022
Life-course socioeconomic conditions, multimorbidity and polypharmacy in older adults: A retrospective cohort study
KT Jungo, B Cheval, S Sieber, L Bernadette Wilhelmina Antonia, A Ihle, ...
PLOS ONE, 2022
The system can't perform the operation now. Try again later.
Articles 1–20